GlassScriptPhysician profile
Grit Adler
NPI 1497981989
$4,599.65
in general payments reported to CMS, 2019-2025
17 companies · $4,052 in 2025
The $4,052 reported for 2025 was more than what 84% of Vascular & Interventional Radiology providers received nationally (typical 2025 total: $537).
See the full distribution for Vascular & Interventional Radiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $120 · 2021: $155 · 2022: $85.31 · 2024: $187 · 2025: $4,052.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,351 · Travel and Lodging: $888.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,351.46 |
| Travel and Lodging | $888.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $1,593.58 | 2022-2025 | Indigo System, Ruby Coil, Penumbra System |
| Stryker Corporation | $758.19 | 2025 | Flowtriever, Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Angiodynamics, INC. | $493.45 | 2025 | Auryon Laser System 100-120 Vac |
| Boston Scientific Corporation | $412.91 | 2025 | General - Embolics, Therasphere Y90 Glass Microspheres 7.0 Gbq (US Commercial), Cryoablation Needles |
| Shockwave Medical, INC | $287.10 | 2025 | |
| Sirtex Medical INC | $220.03 | 2025 | Sir-Spheres Microspheres |
| Inari Medical, INC. | $155.06 | 2021 | |
| Abbott Laboratories | $119.70 | 2024 | Esprit |
| Bard Peripheral Vascular, INC. | $119.70 | 2020 | |
| Merit Medical Systems INC | $119.08 | 2025 | Embosphere Microspheres, Swiftninja Steerable Microcatheter |
| Argon Medical Devices, INC. | $116.49 | 2025 | Clot Management |
| Terumo Medical Corporation | $85.97 | 2025 | Azur Cx Detachable |
| Medtronic, INC. | $33.98 | 2024 | Illumisite |
| Cardiva Medical, INC. | $27.69 | 2025 | Cardiva Vascade 6/7f Vcs |
| Cordis US Corp. | $23.11 | 2025 | Mynx Control |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $17.30 | 2024 | |
| Biogen, INC. | $16.31 | 2024 | Qalsody, Spinraza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Grit Adler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.